Viokace

Product manufactured by Allergan, Inc.

Application Nr Approved Date Route Status External Links
BLA022542 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Viokace Tablets, In Combination With A Proton Pump Inhibitor, Is Indicated In Adults For The Treatment Of Exocrine Pancreatic Insufficiency Due To Chronic Pancreatitis Or Pancreatectomy. ViokaceĀ® Is A Combination Of Porcine-Derived Lipases, Proteases, And Amylases. Viokace, In Combination With A Proton Pump Inhibitor, Is Indicated In Adults For The Treatment Of Exocrine Pancreatic Insufficiency Due To Chronic Pancreatitis Or Pancreatectomy. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 3 Total)

Comments